Cargando…

Deciphering Crosstalk Circuits in Non-small Cell Lung Cancers with an Increasing Interval Length of Low Dose CT Screening

Detalles Bibliográficos
Autores principales:	Rosell, Rafael, Karachaliou, Niki, Chaib, Imane, Pilotto, Sara, Bria, Emilio, Fernández-Martínez, Juan Luis, Ramirez, Jose Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563159/ https://www.ncbi.nlm.nih.gov/pubmed/26425674 http://dx.doi.org/10.1016/j.ebiom.2015.07.026

Ejemplares similares

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
por: Karachaliou, Niki, et al.
Publicado: (2015)

Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2018)

Rhomboids and regulation of receptor tyrosine kinase ligands shedding
por: Karachaliou, Niki, et al.
Publicado: (2018)

Co-mutations in EGFR driven non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2019)

Disulfide isomerase family-6 mediates cisplatin resistance by interfering with apoptosis and autophagy
por: Rosell, Rafael, et al.
Publicado: (2019)

Activation of signal transducer and activator of transcription 3 (STAT3) signaling in EGFR mutant non-small-cell lung cancer (NSCLC)
por: Codony-Servat, Carles, et al.
Publicado: (2017)

Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond
por: Karachaliou, Niki, et al.
Publicado: (2014)

Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
por: Karachaliou, Niki, et al.
Publicado: (2014)

Science and biology drives the immune system to cure lung cancer patients: a revolution but not without challenges
por: Karachaliou, Niki, et al.
Publicado: (2018)

Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
por: Santarpia, Mariacarmela, et al.
Publicado: (2020)

BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib
por: Karachaliou, Niki, et al.
Publicado: (2020)

Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
por: Karachaliou, Niki, et al.
Publicado: (2018)

Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2020)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
por: Moya-Horno, Irene, et al.
Publicado: (2018)

Deciphering the vedolizumab dosing conundrum in IBD: when less is more
por: Adolph, Timon Erik, et al.
Publicado: (2022)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma
por: Ito, Masaoki, et al.
Publicado: (2019)

Long-term survivors with immunotherapy in advanced NSCLC: is ‘cure’ within reach?
por: Monteverdi, Sara, et al.
Publicado: (2020)

The influence of interval between doses on response to vaccines
por: Rodrigues, Charlene M.C., et al.
Publicado: (2021)

Profile of alectinib for the treatment of ALK-positive non-small cell lung cancer (NSCLC): patient selection and perspectives
por: Karachaliou, Niki, et al.
Publicado: (2019)

EGFR first- and second-generation TKIs—there is still place for them in EGFR-mutant NSCLC patients
por: Karachaliou, Niki, et al.
Publicado: (2019)

Deciphering congenital anomalies for the next generation
por: Wojcik, Monica H., et al.
Publicado: (2020)

Deciphering the enigma of neuroendocrine prostate cancer
por: Karzai, Fatima, et al.
Publicado: (2022)

Deciphering Auxin-Ethylene Crosstalk at a Systems Level
por: Zemlyanskaya, Elena V., et al.
Publicado: (2018)

Assays for predicting and monitoring responses to lung cancer immunotherapy
por: Teixidó, Cristina, et al.
Publicado: (2015)

Erratum to Assays for predicting and monitoring responses to lung cancer immunotherapy
por: Teixidó, Cristina, et al.
Publicado: (2015)

Clinical assessment of immune-related adverse events
por: Sosa, Aaron, et al.
Publicado: (2018)

Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2020)

Surprising sirtuin crosstalk in the heart
por: Schug, Thaddeus T., et al.
Publicado: (2010)

Herbgenomics: Decipher molecular genetics of medicinal plants
por: Sun, Wei, et al.
Publicado: (2022)

Expression Profiles and Clinicopathologic Features in Early Resected Non-small-cell Lung Cancer()
por: Rosell, Rafael
Publicado: (2014)

Kisspeptins and norepinephrine regulate different G-protein-coupled receptor signaling pathways
por: Rosell, Rafael, et al.
Publicado: (2022)

Medical emergency teams: deciphering clues to crises in hospitals
por: DeVita, Michael
Publicado: (2005)

Deciphering Metabolic Currencies That Support Marine Microbial Networks
por: Durham, Bryndan P.
Publicado: (2021)

Human endogenous retroviruses and cancer
por: Gonzalez-Cao, María, et al.
Publicado: (2016)

Activation of viral defense signaling in cancer
por: Gonzalez-Cao, Maria, et al.
Publicado: (2018)

Ubiquitin crosstalk connecting cellular processes
por: Groothuis, Tom AM, et al.
Publicado: (2006)

Deciphering the role of natural variation in age-related protein homeostasis
por: Kaeberlein, Matt
Publicado: (2013)

Deciphering the association between HIV-specific immunity and immune reconstitution
por: Søgaard, Ole S.
Publicado: (2021)

Deciphering the autoimmune pathogenesis in fibrillary glomerulonephritis: The story is not yet complete
por: Mubarak, Muhammed
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3hpiqpdjkjsnaumaec4pfcdcc